Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial

Arzneimittelforschung. 2004;54(1):50-6. doi: 10.1055/s-0031-1296936.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / adverse effects
  • Adjuvants, Immunologic / therapeutic use*
  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Bacteria / immunology*
  • Bacterial Vaccines / administration & dosage
  • Bacterial Vaccines / adverse effects
  • Bacterial Vaccines / therapeutic use*
  • Cough / etiology
  • Cough / pathology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pain / etiology
  • Respiratory Tract Infections / complications
  • Respiratory Tract Infections / prevention & control*
  • Sputum

Substances

  • Adjuvants, Immunologic
  • Anti-Bacterial Agents
  • Bacterial Vaccines